<p>The fraction neutralized is plotted against the concentration of Fab sites. The inserts in A, B and C are the calculated values of from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1003431#pcbi.1003431.e136" target="_blank">Eq. (7)</a> and <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1003431#pcbi.1003431.e162" target="_blank">(10)</a> versus the concentration of Fab sites for and the parameters given in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1003431#pcbi-1003431-t002" target="_blank">Table 2</a>. Neutralization by A. 2F5 Fab (red circles) and two preparations of 2F5 IgG (solid squares and open circles), B. 4E10 Fab (blue squares) and 4E10 Ig...
<p>Reductions in infectious virus are calculated as the ratio of the titer (V<sub>t</sub>) at time t...
<p>(A) Titration of PF74 or indicated derivatives onto HeLa cells infected with VSV-G pseudotyped GF...
<p>The IC<sub>50</sub> values were estimated from the titration curves of all mAb/psV combinations a...
<p>The neutralization curves of anti-V3 mAb 2191 against nine selected HIV-1 pseudoviruses are shown...
<p>The graphs show percent neutralization versus BMS purified IgG (A) or IgA (B) dilution. The corre...
<p>Representative graphs showing percent neutralization versus BMS purified IgG or IgA dilution. (a)...
<p>(A) Scheme depicting the combined experimental-mathematical approach employed here to estimate N....
<p>Summary of neutralization breadth of individual mAbs from previously published experiments. The c...
<p>(A) Scheme depicting the virus and nAb-specific parameters necessary to predict HIV-1 neutralizat...
<p>Seven anti-V3 mAbs (2191, 2219, 2557, 2558, 3074, 3869, and 447) were tested for neutralization a...
The neutralization phenotypes of HIV-1 mAbs and polyclonal mixtures from subjects VC10014 and VC2001...
<p>Neutralizing titers corresponding to 50% inhibition of the reporter luciferase activity (compared...
<p>Analysis of breadth by neutralization of various tiered HIV-1 Env pseudoviruses by 2wp3 (p3) and ...
<p>Varied concentrations of neutralizing antibodies against distinct domains of HIV-1 gp120, PG9 (A)...
<p>(A, B, C, D) Each spoke represents a strain of HIV neutralized by B9 (A), B21 (B) A14 (C) and 3E3...
<p>Reductions in infectious virus are calculated as the ratio of the titer (V<sub>t</sub>) at time t...
<p>(A) Titration of PF74 or indicated derivatives onto HeLa cells infected with VSV-G pseudotyped GF...
<p>The IC<sub>50</sub> values were estimated from the titration curves of all mAb/psV combinations a...
<p>The neutralization curves of anti-V3 mAb 2191 against nine selected HIV-1 pseudoviruses are shown...
<p>The graphs show percent neutralization versus BMS purified IgG (A) or IgA (B) dilution. The corre...
<p>Representative graphs showing percent neutralization versus BMS purified IgG or IgA dilution. (a)...
<p>(A) Scheme depicting the combined experimental-mathematical approach employed here to estimate N....
<p>Summary of neutralization breadth of individual mAbs from previously published experiments. The c...
<p>(A) Scheme depicting the virus and nAb-specific parameters necessary to predict HIV-1 neutralizat...
<p>Seven anti-V3 mAbs (2191, 2219, 2557, 2558, 3074, 3869, and 447) were tested for neutralization a...
The neutralization phenotypes of HIV-1 mAbs and polyclonal mixtures from subjects VC10014 and VC2001...
<p>Neutralizing titers corresponding to 50% inhibition of the reporter luciferase activity (compared...
<p>Analysis of breadth by neutralization of various tiered HIV-1 Env pseudoviruses by 2wp3 (p3) and ...
<p>Varied concentrations of neutralizing antibodies against distinct domains of HIV-1 gp120, PG9 (A)...
<p>(A, B, C, D) Each spoke represents a strain of HIV neutralized by B9 (A), B21 (B) A14 (C) and 3E3...
<p>Reductions in infectious virus are calculated as the ratio of the titer (V<sub>t</sub>) at time t...
<p>(A) Titration of PF74 or indicated derivatives onto HeLa cells infected with VSV-G pseudotyped GF...
<p>The IC<sub>50</sub> values were estimated from the titration curves of all mAb/psV combinations a...